catechin and Escherichia coli Infections

catechin has been researched along with Escherichia coli Infections in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Ayala-Zavala, JF; Bernal-Mercado, AT; Encinas-Basurto, D; Gonzalez-Aguilar, GA; Gutierrez-Pacheco, MM; Islas-Osuna, MA; Lopez-Zavala, AA; Mata-Haro, V1
Bhaskaran, S; Hari, N; Solomon, AP; Thamil Selvan, G; Vasudevan, S1
Hou, A; Li, K; Li, Z; Tian, X; Wang, Y; Xie, J1
Fan, S; Li, J; Li, W; Sama, AE; Tracey, KJ; Tsai, S; Wang, H; Wang, P; Zhao, L; Zhu, S1
Cho, YH; Ha, US; Han, CH; Kim, HW; Lee, CB; Lee, SJ; Sohn, DW; Yoon, BI1
Cho, YH; Han, CH; Kang, SH; Kim, SW; Lee, SJ; Lee, YS; Shin, OR; Sim, YC1
Isogai, E; Isogai, H; Nishikawa, T; Takeshi, K1
Hayashi, S; Hirose, K; Isogai, E; Isogai, H; Oguma, K1

Other Studies

8 other study(ies) available for catechin and Escherichia coli Infections

ArticleYear
Synergistic mode of action of catechin, vanillic and protocatechuic acids to inhibit the adhesion of uropathogenic Escherichia coli on silicone surfaces.
    Journal of applied microbiology, 2020, Volume: 128, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Catechin; Catheters; Drug Synergism; Escherichia coli Infections; Fimbriae, Bacterial; Humans; Hydroxybenzoates; Phenols; Silicones; Urinary Tract Infections; Uropathogenic Escherichia coli; Vanillic Acid

2020
Reciprocal Cooperation of Type A Procyanidin and Nitrofurantoin Against Multi-Drug Resistant (MDR) UPEC: A pH-Dependent Study.
    Frontiers in cellular and infection microbiology, 2020, Volume: 10

    Topics: Biflavonoids; Biofilms; Catechin; Escherichia coli Infections; Humans; Hydrogen-Ion Concentration; Nitrofurantoin; Pharmaceutical Preparations; Proanthocyanidins; Urinary Tract Infections; Uropathogenic Escherichia coli

2020
Proteomic changes in EHEC O157:H7 under catechin intervention.
    Microbial pathogenesis, 2018, Volume: 123

    Topics: Anti-Bacterial Agents; Bile Acids and Salts; Catechin; Escherichia coli Infections; Escherichia coli O157; Gastrointestinal Tract; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Proteome

2018
Green tea catechins quench the fluorescence of bacteria-conjugated Alexa fluor dyes.
    Inflammation & allergy drug targets, 2013, Volume: 12, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Catechin; Cells, Cultured; Coinfection; Escherichia coli; Escherichia coli Infections; Fluorescence; Humans; Hydrazines; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Organic Chemicals; Staphylococcal Infections; Staphylococcus aureus; Theaceae

2013
Anti-inflammatory and antimicrobial effects of nanocatechin in a chronic bacterial prostatitis rat model.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Catechin; Chronic Disease; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Humans; Male; Prostate; Prostatitis; Rats; Rats, Wistar

2011
Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model.
    International journal of urology : official journal of the Japanese Urological Association, 2005, Volume: 12, Issue:4

    Topics: Animals; Anti-Infective Agents; Catechin; Chronic Disease; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Follow-Up Studies; Male; Prostate; Prostatitis; Random Allocation; Rats; Rats, Wistar; Treatment Outcome; Urine

2005
Protective effect of Japanese green tea extract on gnotobiotic mice infected with an Escherichia coli O157:H7 strain.
    Microbiology and immunology, 1998, Volume: 42, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Catechin; Disease Models, Animal; Escherichia coli Infections; Escherichia coli O157; Female; Male; Mice; Tea

1998
In vivo synergy between green tea extract and levofloxacin against enterohemorrhagic Escherichia coli O157 infection.
    Current microbiology, 2001, Volume: 42, Issue:4

    Topics: Animals; Anti-Infective Agents; Catechin; Colony Count, Microbial; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Escherichia coli Infections; Escherichia coli O157; Feces; Female; Germ-Free Life; Levofloxacin; Male; Mice; Mice, Inbred ICR; Ofloxacin; Plant Extracts; Shiga Toxin; Tea

2001